Back to search
FDAFDA · Food and drugs·Recall number Z-1502-2025

Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time test and factor assays.

Published April 9, 2025 · Recall initiated: March 6, 2025

Summary

FDA records medical device Class II recall Z-1502-2025, published April 9, 2025 and initiated March 6, 2025. Recalling firm: Fisher Diagnostics; Status: Ongoing; Reported quantity: 4,387 units; Lot: Catalog No. 100356; UDI: 00845275000542719170261130100356; Lot No. 719170; Exp. Date 11/30/26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fisher Diagnostics
Distributor
US Distribution to: PA and OUS Foreign country of: United Arab Emirates.
Lot
Catalog No. 100356; UDI: 00845275000542719170261130100356; Lot No. 719170; Exp. Date 11/30/26.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time test and factor assays. recalled?

Yes. FDA published recall Z-1502-2025 on April 9, 2025. Reported hazard: The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.

What should I do if I have this product?

Voluntary: Firm initiated · Letter